Proportion of women in trials, registries and population statistics (median (IQR))
| Trial | Registries | Population | P value (trials to registries) | P value (trials to population) | |
| HF, LVEF <35% | 21.4 (17.7–25.7) | 25.4 (23.7–27.2) | 28.2 (26.0–30.4) | 0.21 | 0.02 |
| HF, LVEF <50% | 24.3 (21.7–32.0) | 31.7 (31.2–37.0) | 33 (29.0–40.0) | 0.14 | 0.03 |
| All HF (no LVEF specified) | 36.5 (29.2–47.2) | 44.9 (33.9–52.8) | 50.1 (48.0–51.8) | 0.08 | <0.01 |
| HF, LVEF >50% | 51.6 (48.6–52.0) | 54.8 (50.8–61.0) | 56.5 (52.2–64.8) | 0.15 | 0.01 |
| All | 25.8 (21.3–36.0) | 40.2 (32.3–52.8) | 49.0 (38.2–53.4) | <0.01 | <0.01 |
HF, heart failure; LVEF, left ventricular ejection fraction.